Are Only 2 Stocks of Stan’s On Sale?
Stanley Druckenmiller has an exemplary history and track record trading so we wanted to investigate whether any opportunities leap out in his current portfolio.
Which positions, if any, are underwater? And are there any diamonds in the rough now that are on sale?
In Druckenmiller’s Duquesne Family Office there are 75 stock positions as of September 30, » Read more about: Are Only 2 Stocks of Stan’s On Sale? »
Read More
1 Really Cheap Dividend Stock with 25.2% Upside
Dollar General has underperformed the market by 69% this year, posting a year-to-date loss of 53% but perhaps the decline has provided value investors with a new opportunity now that the price-to-earnings ratio is just 11.7x, almost half the multiple of the S&P 500.
Read More
Market Commentary: Time To Buy This 9.12% Yield Stock?
It’s rare to find a stock offering a 9%+ yield that doesn’t have some murkiness under the hood, but is Medical Properties Trust (NYSE: MPW) that diamond in the rough?
We investigate whether this REIT that specializes in leasing healthcare facilities, a segment that has been traditionally regarded as recession-resistant, is worthy of a portfolio spot now.
» Read more about: Market Commentary: Time To Buy This 9.12% Yield Stock? »
Read More
Market Commentary: 1 Monthly Income Play You Don’t Want To Miss
If getting paid passively monthly sounds like something you’ve been looking for, Realty Income might be just the stock you’ve been looking for. From a single store 54 years ago, Realty Income is now a true behemoth that rewards investors seeking monthly income.
Read More
The Formula Behind Billionaire’s 30-Year Win Streak
Stanley Druckenmiller may be best known for his role with George Soros in shorting the British pound in 1992, which famously became known as breaking the Bank of England. That position resulted in a cumulative profit of over a billion dollars, and all while Druckenmiller was only in his late 30s.
At a time when many professional investors consider themselves in their early innings of their careers,
» Read more about: The Formula Behind Billionaire’s 30-Year Win Streak »
Read MoreThe Burst
Is This Fintech Set To Explode?
Fintech lender and financial services provider SoFi (NASDAQ:SOFI) was among the companies hit hard by the stock crash of 2021. At its peak, the company’s shares traded at over $25. Today, the stock is priced under $10 per share.
Recent developments, however, have given SoFi some renewed momentum and opened up the strong possibility of a turnaround.
» Read more about: Is This Fintech Set To Explode? »
Read MoreThe Spotlight
Spotlight: Time To Buy Vaccine Manufacturer Before Winter?
It’s impossible to discuss Moderna without mentioning its COVID-19 vaccine, which propelled the stock to record highs in 2021 approaching $500 per share. However, slower sales caused the stock to plunge by almost 80%.
Second-quarter reports in 2023 show a net loss of $1.38 billion, a stark contrast to the net income of $5.4 billion in Q4 2021.
» Read more about: Spotlight: Time To Buy Vaccine Manufacturer Before Winter? »
Read MoreThe Daily
Worried Investors Should Buy Warren Buffett’s Dividend Safety Stocks
The 10-year Treasury note was trading at a 4.75% yield in January and is now at a 4.09%.
» Read more about: Worried Investors Should Buy Warren Buffett’s Dividend Safety Stocks »